Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Oct 1, 2021 (5 years ago)

Lotrimin Af

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Cause type: Chemical / undeclared

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines. All chemical / undeclared recalls.

What was recalled

LOTRIMIN AF (Miconazole nitrate 2%) Powder Spray NET WT 133g (4.6 OZ) can, packaged as (a) a single pack NDC 11523-0544-2 UPC 3 11017 41025 7; (b) 3 pack, NDC 11523-0544-2, UPC 0 41100 58594 3; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, ,

Affected NDC 11523-0544-02

Compare with the code on your package — it is the most precise check available.

Drug: Miconazole

Recalling firm
Bayer Healthcare Pharmaceuticals Inc.
NDC code
11523-0544-2
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0238-2022 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Miconazole recalls

See all
Class II · Moderate risk

DermaFungal

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Ongoing cGMP deviation DermaRite Industries, LLC NDC 61924-234-05 D-0162-2026
Class II · Moderate risk

Medline Remedy Clinical TREAT Antifungal Cream

Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list.

Ongoing Labeling / mix-up MEDLINE INDUSTRIES, LP - Northfield D-0315-2024
Class II · Moderate risk

Clinical TREAT Antifungal Powder

CGMP deviations: the product was shipped from the Manufacturer to a Medline warehouse and released to stock while it was still under investigation for low assay results on the active ingredient miconazole nitrate.

Terminated Wrong potency / content MEDLINE INDUSTRIES, LP - Northfield D-0091-2024

Other recalls by Bayer Healthcare Pharmaceuticals Inc.

All 2021 recalls
Class I · High risk

VITRAKVI (larotractenib)

Microbial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing

Terminated Microbial contamination Bayer Healthcare Pharmaceuticals Inc. NDC 50419-392-01 D-0145-2024
Class II · Moderate risk

Lotrimin Af

cGMP Deviations: LOTRIMIN AF (Tolnaftate 1%) manufactured at the same facility where other lots were found to be contaminated with benzene.

Terminated Chemical / undeclared Bayer Healthcare Pharmaceuticals Inc. NDC 11523-0010-2 D-0254-2022